Expert Review of Vaccines

Article	Citations
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?	194
Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States	174
Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis	92
Parental category B vaccine hesitancy and associated factors in China: an online cross-sectional survey	92
Indirect protection from rotavirus vaccines: a systematic review	88
Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response	80
Relationship between attitudes toward the effectiveness of vaccine, concerns about adverse reactions, and proactively taking SARS-Cov-2 vaccine for family among medical workers in Taizhou, China	73
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant	64
Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy	62
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic	60
The important lessons lurking in the history of meningococcal epidemiology	59
Evaluation strategies for measuring pneumococcal conjugate vaccine impact in low-resource settings	59
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era	58
Effectiveness of maternal vaccination with quadrivalent inactivated influenza vaccine in pregnant women and their infants in 2019-2020	56
The protective effects of two varicella vaccination strategies: A Bayesian modeling study in two megacities in South China	55
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis	52
Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness	49
Response to letter to the editor on a systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	44
Response to Feemster KA et al. letter to the editor on Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumo	44
Personal and contextual determinants of COVID-19 vaccination intention: a vignette study	43
Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays	41
Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment	39
Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis	38
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review	37
Microarray patches: scratching the surface of vaccine delivery	36

Waning intra-season vaccine effectiveness against influenza A(H3N2) underlines the need for more durable protection	36
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom	35
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China	35
Anti-COVID-19 vaccines and rare cases of cerebral venous sinus thrombosis with thrombocytopenia: what about the pragmatic benefit/risk evaluation for still unvaccinated young women	35
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis	35
Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above	34
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy	33
Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond	33
Vaccines against leishmaniasis: using controlled human infection models to accelerate development	33
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT): A review of the evidence and expert opinion	32
Cost-effectiveness of cell-based influenza vaccine in France	31
Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in Germany	31
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment	31
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative	30
Immunization in pregnancy to protect pregnant people and their newborns against COVID-19	30
Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines	29
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan	29
Looking to the future: is a universal coronavirus vaccine feasible?	28
Comparing reactogenicity of COVID-19 vaccine boosters: a systematic review and meta-analysis	28
COVID-19 vaccines approved in the European Union: current evidence and perspectives	27
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States	27
TAK-003: development of a tetravalent dengue vaccine	26
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China	26
Regional molecular epidemiology of dengue and the potential optimization of its control through the use of vaccines. Report of the Arbovirus Committee of the Latin American Society of Pediatric Infect	25
Self-controlled case series design in vaccine safety: a systematic review	25
Genetic predisposition to adverse events in Chinese children aged 3-24 months after diphtheria, tetanus, acellular pertussis and haemophilus influenzae type b combined vaccination	25
COVID-19 vaccine trials and sex-disaggregated data	25
COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021	25
COVID-19 vaccination in pregnant and lactating women: a systematic review	24
The burden of seasonal influenza: improving vaccination coverage to mitigate morbidity and its impact on healthcare systems	24
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China	24
Travelers’ preferences for tick-borne encephalitis vaccination	24
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers	24
Vaccines against mpox: MVA-BN and LC16m8	23
Modeling the potential public health and economic impact of COVID-19 vaccination strategies using an adapted vaccine in Peru	23
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months o	23
Anti-neuraminidase immunity in the combat against influenza	23
Adjuvant system AS01: from mode of action to effective vaccines	23
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis	23
An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: Validation of the Pro-VC-Be questionnaire	23
Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges	23
A descriptive review on the real-world impact of Moderna, Inc. COVID-19 vaccines	22
Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccination	22
The durability of vaccine-induced protection: an overview	20
Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine	20
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China	20
Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children	19
Safety of primary immunization with a DTwP-HBV/Hib vaccine in healthy infants: a prospective, open-label, interventional, phase IV clinical study	19
Innovation and immunization program management: traceability and quality in Latin America and the Caribbean, laying the groundwork for a regional action plan	19
Immunization in state of siege: the importance of thermostable vaccines for Ukraine and other war-torn countries and territories	19

Suspended cell lines for inactivated virus vaccine production	19
Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States	18
Estimating the time required to reach HPV vaccination targets across Europe	18
Impact of rotavirus vaccination on diarrheal disease burden of children in South America	18
Toward an effective Staphylococcus vaccine: why have candidates failed and what is the next step?	18
Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review	17
Mapping and ranking outcomes for the evaluation of seasonal influenza vaccine efficacy and effectiveness: a delphi study	17
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK	17
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine	17
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study	17
Public health impact and return on investment of the pediatric immunization program in Poland	17
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review	17
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination	17
The associations of geographic location and perceived risk of infection with the intentions to get vaccinated against COVID-19 in China	17
A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome	17
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks	17
Development of a recombinant vaccine against human onchocerciasis	16
Expert review on global real-world vaccine effectiveness against SARS-CoV-2	16
Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?	16
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses	16
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey	16
Eyedrop vaccination: an immunization route with promises for effective responses to pandemics	16
Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs	16
Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study	15
Have mRNA vaccines sentenced DNA vaccines to death?	15
Screening of tumor antigens and immunogenic cell death landscapes of prostate adenocarcinoma for exploration of mRNA vaccine	15
Next generation live-attenuated influenza vaccine platforms	15
Making COVID-19 mRNA vaccines accessible: challenges resolved	15
Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older	15
PPSV-23 recommendation and vaccination coverage in China: a cross-sectional survey among healthcare workers, older adults and chronic disease patients	14
Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice	14
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza	14
Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution	14
Correspondence on ‘Herpes Zoster and Simplex reactivation following COVID-19 vaccination’	14
Vaccination strategies for solid organ transplant candidates and recipients: insights and recommendations	14
Lymphatic filariasis vaccine development: neglected for how long?	14
Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis	14
Vaccines against SARS-CoV-2 variants and future pandemics	14
Reverse engineering approach: a step towards a new era of vaccinology with special reference to Salmonella	14
Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions	13
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage	13
Time lapses between distribution of influenza vaccines to health authorities and their administration by General Practitioners (GPs) to older adults: a retrospective study over five influenza seasons	13
Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives	13
Health behaviors are largely not predictive of adverse events following influenza vaccination	13
COVID-19 and vaccination: myths vs science	13
Correlates of protection for meningococcal surface protein vaccines: lessons from the past	13
Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan	13
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines	13
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China	13
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years	13
Rotavirus vaccines performance: dynamic interdependence of host, pathogen and environment	13
Correction	13
What are the challenges faced by COVID-19 vaccines?	12
An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants	12
Reply to: correspondence on “Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis​”	12
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context	12
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis	12
Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches	12
Trends in adolescent and adult vaccination in pharmacy and medical settings in the United States, 2018–2024: a database study	12
Emergence of mRNA vaccines in the management of cancer	12
A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson’s disease	12
Nanovaccine: an emerging strategy	12
An overview: CRISPR/Cas-based gene editing for viral vaccine development	12
Subolesin: a 20-year path from discovery to an effective tick vaccine	12
Vaccine for a neglected tropical disease Taenia solium cysticercosis: fight for eradication against all odds	12
Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand	12
Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data	12
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh	12
Strengths and limitations of non-survey-based data sources for assessing adult vaccination coverage in the United States	11
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines	11
Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai, China	11
Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China	11
Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore	11
Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions	11
Immunization funding across 28 European countries	11
Recent advances in lipopolysaccharide-based glycoconjugate vaccines	11
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection	11
Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	11
Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen	11
Sars-Cov-2 virus and vaccination; biological and statistical framework	11

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy	11
Health economic analyses of secondary vaccine effects: a systematic review and policy insights	10
COVID-19 vaccine design and vaccination strategy for emerging variants	10
Cost-effectiveness of nonavalent HPV vaccination in the Netherlands	10
A review of data systems for assessing the impact of HPV vaccination in selected high-income countries	10
Approaches in broadening the neutralizing antibody response of the influenza vaccine	10
Response to: “immunization in state of siege: the importance of thermostable vaccines for Ukraine and other war-torn countries and territories”	10
The role of bactericidal and opsonic activity in immunity against Bordetella pertussis	10
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes	10
Research progress on immune mechanism and control strategy of dsRNA impurities in mRNA vaccine	10
Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data	10
Tackling vaccine inequity in 2023: have we made progress?	10
Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies	10
Modeling the potential public health and economic impact of different COVID-19 vaccination strategies with an adapted vaccine in the Kingdom of Saudi Arabia	10
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness	10
Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan	10
Adult vaccination against respiratory infections in Egypt: a review of expert opinions	10
Measuring psychosocial determinants of vaccination behavior in healthcare professionals: validation of the Pro-VC-Be short-form questionnaire	10
No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study	10
Application of reverse cumulative distribution curve and scaled logit model in determining optimal immunogenic dose and prediction of protection of EV71 vaccines	10
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant	10
Risk of herpes zoster following mRNA COVID-19 vaccine administration	9
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis	9
The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines	9
Global impact of delta plus variant and vaccination	9
Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial	9
Respiratory syncytial virus infection and the need for immunization in Korea	9
Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity	9
Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs	9
Efficacy, immunogenicity, and evidence for best-timing of pneumococcal vaccination in splenectomized adults: a systematic review	9
The use of electroporation to deliver DNA-based vaccines	9
Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses	9
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies	9
Immune response and safety of inactivated SARS-CoV-2 vaccines during pregnancy: a real-world observational study	9
Immunomodulatory regulation by heat-labile enterotoxins and potential therapeutic applications	8
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy	8
No observable influence of COVID-19 inactivated vaccines on pregnancy and birth outcomes in the first trimester of gestation	8
Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults	8
Adverse events following influenza immunization: understanding the role of age and sex interactions	8
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis	8
Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)	8
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers	8
The zebrafish as a potential model for vaccine and adjuvant development	8
The broader benefits of vaccines: methodologies for inclusion in economic evaluation	8
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis	8
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis	8
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020	8
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations	8
A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia	8
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong	8
The quest for an HIV-1 vaccine: will mRNA deliver us from evil?	8
Human lymph node immune dynamics as driver of vaccine efficacy: an understudied aspect of immune responses	8
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India	8
Vaccination against pertussis in Latin American preterm and low-birth weight infants: experts opinion position for a neglected childhood age group	8
Safety outcomes associated with the moderna COVID-19 vaccine (mRNA-1273): a literature review	8
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital	8
Changing epidemiology of COVID-19: potential future impact on vaccines and vaccination strategies	8
Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children	8
Combatting infectious diarrhea: innovations in treatment and vaccination strategies	8
Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate	8
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study	8
Adult vaccination in three Eastern Mediterranean countries: current status, challenges and the way forward	8
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis	7
Cost-effectiveness of the 15-valent pneumococcal conjugate vaccine for high-risk adults in Switzerland	7
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?	7
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?	7
Typhoid conjugate vaccines: is a single dose enough for durable protection?	7
The potential of intrinsically disordered regions in vaccine development	7
Carbohydrate-containing nanoparticles as vaccine adjuvants	7
Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)	7
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England	7
Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights	7
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines	7
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	7
COVID-19 vaccines: the start of a new era in regulation?	7
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews	7
Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities	7
The effect of COVID-19 mRNA vaccines against postvaccination laboratory-confirmed SARS-CoV-2 infection, symptomatic COVID-19 infection, hospitalization, and mortality rate: a systematic review and met	7
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials	7
Novel approaches to reactivate pertussis immunity	7
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece	7
Clinical development and approval of COVID-19 vaccines	7
Immune mechanisms targeting malaria transmission: opportunities for vaccine development	7
Eliminating nonmedical exemptions: a radical shift in how childhood vaccine mandates govern	7
Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review	6
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines	6
Correction	6
Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?	6
The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development	6
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing	6
Comparative efficacy of human papillomavirus vaccines: systematic review and network meta-analysis	6
Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine	6
Chlamydia trachomatisvaccine development – a view on the current challenges and how to move forward	6
Immunization information systems’ implementation and characteristics across the world: a systematic review of the literature	6
Generation of the therapeutic monoclonal antibody NEO-201, derived from a cancer vaccine, which targets human malignancies and immune suppressor cells	6